Login / Signup

Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.

Niccolò GoriElena IppolitiSilvia Mariel FerrucciAnna BalatoMichela OrtoncelliMartina MaurelliMarco GalluzzoMonica Munera CamposTeofila SeremetLucia Di NardoFlaminia AntonelliGiulia CoscarellaCurdin ConradY José Manuel CarrascosaLuca BianchiGiuseppe ArgenzianoSimone RiberoGiampiero GirolomoniAngelo Valerio MarzanoAndrea ChiricozziKetty Perisnull null
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • patient reported outcomes
  • atopic dermatitis